|
LATISSE®
FAQ's
FDA-Approved PATIENT INFORMATION
What is LATISSE™ solution?
LATISSE™ solution is a prescription treatment for hypotrichosis used to grow
eyelashes, making them longer, thicker
and darker.
Who should NOT take LATISSE™?
Do not use LATISSE™ solution if you
are allergic to one of its ingredients.
Are there any special warnings
associated with LATISSE™ use?
LATISSE™ solution is intended for use
on the skin of the upper eyelid margins at the base of the eyelashes. Refer to
Illustration 2 below. DO NOT APPLY to the lower eyelid. If you are using LUMIGAN®
or other products in the same class for elevated intraocular pressure (IOP), or
if you have a history of abnormal IOP, you should only use LATISSE™ under the
close supervision of your physician.
LATISSE™ use may cause darkening of the eyelid skin which may be reversible.
LATISSE™ use may also cause increased brown pigmentation of the colored part of
the eye which is likely to be permanent. It is possible for hair growth to occur
in other areas of your skin that LATISSE™ frequently touches. Any excess
solution outside the upper eyelid margin should be blotted with a tissue or
other absorbent material to reduce the chance of this from happening. It is also
possible for a difference in eyelash length, thickness, fullness, pigmentation,
number of eyelash hairs, and/or direction of eyelash growth to occur between
eyes. These differences, should they occur, will
usually go away if you stop using LATISSE™.
Who should I tell that I am using LATISSE™?
You should tell your physician you are
using LATISSE™ especially if you have a history of eye pressure problems. You
should also tell anyone conducting an eye pressure screening that you are using
LATISSE™.
What should I do if I get LATISSE™ in my eye?
LATISSE™ solution is an ophthalmic
drug product. LATISSE™ is not expected to cause harm if it gets into the eye
proper. Do not attempt to rinse your eye in this situation.
What are the possible side effects of LATISSE™?
The most common side effects after using LATISSE™ solution are an itching
sensation in the eyes and/or eye redness. This was reported in approximately 4%
of patients. LATISSE™ solution may cause other less common side effects which
typically occur on the skin close to where LATISSE™ is applied, or in the eyes.
These include skin darkening, eye irritation, dryness of the eyes, and redness
of the eyelids. If you develop a new ocular condition (e.g., trauma or
infection), experience a sudden decrease in visual acuity, have ocular surgery,
or develop any ocular reactions, particularly conjunctivitis and eyelid
reactions, you should immediately seek your physician’s advice concerning the
continued use of LATISSE™ solution.
What happens if I stop using LATISSE™?
If you stop using LATISSE™, your eyelashes are expected to return to their
previous appearance over several weeks to months. Any eyelid skin darkening is
expected to reverse after several weeks to months. Any darkening of the colored
part of the eye known as the iris is NOT expected to reverse and is likely
permanent.
How do I use LATISSE™?
LATISSE™ solution is packaged as a 3 mL bottle of solution with 60 accompanying
sterile, disposable applicators. The recommended dosage is one application
nightly to the skin of the upper eyelid margin at the base of the eyelashes
only. Once nightly, start by ensuring your face is clean, makeup and contact
lenses are removed. Remove an applicator from its tray. Then, holding the
sterile applicator horizontally, place one drop of LATISSE™ on the area of the
applicator closest to the tip but not on the tip (see Illustration 1). Then
immediately draw the applicator carefully across the skin of the upper eyelid
margin at the base of the eyelashes (where the eyelashes meet the skin) going
from the inner part of your lash line to the outer part (see Illustration 2).
Blot any excess solution beyond the eyelid margin. Dispose of the applicator
after one use. Repeat for the opposite upper eyelid margin using a new sterile
applicator. This helps minimize any potential for
contamination from one eyelid to another.
|
Illustration 1 |
Illustration 2 |
|
|
